Ngā hua rapu - Pascal Maisonobe

  • E whakaatu ana i te 1 - 15 hua o te 15
Whakamahine hua
  1. 1
    Results from the Upper Limb International Spasticity Study-II (ULIS-II): a large, international, prospective cohort study investigating practice and goal attainment following treatment with botulinum toxin A in real-life clinical management

    Results from the Upper Limb International Spasticity Study-II (ULIS-II): a large, international, prospective cohort study investigating practice and goal attainment following treat... mā Lynne Turner‐Stokes, Klemens Fheodoroff, Jorge Jacinto, Pascal Maisonobe

    I whakaputaina 2013
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  2. 2
    Upper limb international spasticity study: rationale and protocol for a large, international, multicentre prospective cohort study investigating management and goal attainment following treatment with botulinum toxin A in real-life clinical practice

    Upper limb international spasticity study: rationale and protocol for a large, international, multicentre prospective cohort study investigating management and goal attainment foll... mā Lynne Turner‐Stokes, Klemens Fheodoroff, Jorge Jacinto, Pascal Maisonobe, Benjamin Zakine

    I whakaputaina 2013
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  3. 3
    Factors influencing response to Botulinum toxin type A in patients with idiopathic cervical dystonia: results from an international observational study

    Factors influencing response to Botulinum toxin type A in patients with idiopathic cervical dystonia: results from an international observational study mā V.P. Misra, Edvard Ehler, Benjamin Zakine, Pascal Maisonobe, M. Simonetta‐Moreau

    I whakaputaina 2012
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  4. 4
    Control of IGF‐I levels with titrated dosing of lanreotide Autogel over 48 weeks in patients with acromegaly

    Control of IGF‐I levels with titrated dosing of lanreotide Autogel over 48 weeks in patients with acromegaly mā Philippe Chanson, Françoise Borson‐Chazot, Jean‐Marc Kuhn, Joëlle Blumberg, Pascal Maisonobe, Brigitte Delemer

    I whakaputaina 2008
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  5. 5
    INTEREST IN CD2, a global patient-centred study of long-term cervical dystonia treatment with botulinum toxin

    INTEREST IN CD2, a global patient-centred study of long-term cervical dystonia treatment with botulinum toxin mā V.P. Misra, Carlo Colosimo, David Charles, Tae Mo Chung, Pascal Maisonobe, Savary Om

    I whakaputaina 2017
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  6. 6
    Muscle selection and dosing in patients undergoing treatment with abobotulinumtoxinA for lower limb spasticity in real-world practice

    Muscle selection and dosing in patients undergoing treatment with abobotulinumtoxinA for lower limb spasticity in real-world practice mā Richard D. Zorowitz, Jorge Jacinto, Stephen Ashford, Mathieu Beneteau, Pascal Maisonobe, Christian Hannes, Alberto Esquenazi

    I whakaputaina 2025
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  7. 7
    Tumor Shrinkage With Lanreotide Autogel 120 mg as Primary Therapy in Acromegaly: Results of a Prospective Multicenter Clinical Trial

    Tumor Shrinkage With Lanreotide Autogel 120 mg as Primary Therapy in Acromegaly: Results of a Prospective Multicenter Clinical Trial mā Philippe Caron, John S. Bevan, Stephan Petersenn, Daniel Flanagan, Antoine Tabarin, Gaëtan Prévost, Pascal Maisonobe, Antoine Clermont

    I whakaputaina 2013
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  8. 8
    Symptomatic Treatment With Lanreotide Microparticles in Inoperable Bowel Obstruction Resulting From Peritoneal Carcinomatosis: A Randomized, Double-Blind, Placebo-Controlled Phase III Study

    Symptomatic Treatment With Lanreotide Microparticles in Inoperable Bowel Obstruction Resulting From Peritoneal Carcinomatosis: A Randomized, Double-Blind, Placebo-Controlled Phase... mā Pascale Mariani, Joëlle Blumberg, Alain Landau, Daniela Lebrun-Jezekova, Estelle Botton, Olivier Béatrix, Didier Mayeur, Robert Hervé, Pascal Maisonobe, L. Chauvenet

    I whakaputaina 2012
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  9. 9
    Factors and Regional Differences Associated with Endometriosis: A Multi-Country, Case–Control Study

    Factors and Regional Differences Associated with Endometriosis: A Multi-Country, Case–Control Study mā Charles Chapron, Jinghe Lang, Jinhua Leng, Yingfang Zhou, Xinmei Zhang, Min Xue, А. А. Попов, Vladimir Romanov, Pascal Maisonobe, Patrick Cabri

    I whakaputaina 2016
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  10. 10
    Patient-reported outcomes with lanreotide Autogel/Depot for carcinoid syndrome: An international observational study

    Patient-reported outcomes with lanreotide Autogel/Depot for carcinoid syndrome: An international observational study mā Philippe Ruszniewski, Juan W. Valle, Catherine Lombard‐Bohas, Daniel J. Cuthbertson, Petros Perros, L Holubec, Gianfranco Delle Fave, Denis Smith, Patricia Niccoli, Pascal Maisonobe, Philippe Atlan, Martyn Caplin

    I whakaputaina 2016
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  11. 11
    Lanreotide Autogel 120 mg at extended dosing intervals in patients with acromegaly biochemically controlled with octreotide LAR: the LEAD study

    Lanreotide Autogel 120 mg at extended dosing intervals in patients with acromegaly biochemically controlled with octreotide LAR: the LEAD study mā Sebastian JCMM Neggers, Vyacheslav Pronin, Inga Balcere, Moon‐Kyu Lee, Liudmila Rozhinskaya, Marcello D. Bronstein, Mônica R. Gadelha, Pascal Maisonobe, Caroline Sert, Aart Jan van der Lely, NULL AUTHOR_ID

    I whakaputaina 2015
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  12. 12
    Early AbobotulinumtoxinA (Dysport®) in Post-Stroke Adult Upper Limb Spasticity: ONTIME Pilot Study

    Early AbobotulinumtoxinA (Dysport®) in Post-Stroke Adult Upper Limb Spasticity: ONTIME Pilot Study mā Raymond L. Rosales, Jovita Balcaitiene, Hugues Berard, Pascal Maisonobe, Khean Jin Goh, Witsanu Kumthornthip, Mazlina Mazlan, Lydia Abdul Latif, Mary Mildred Delgado-Delos Santos, Chayaporn Chotiyarnwong, Phakamas Tanvijit, Odessa Setiota Nuez, Keng He Kong

    I whakaputaina 2018
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  13. 13
    Antiproliferative effects of lanreotide autogel in patients with progressive, well-differentiated neuroendocrine tumours: a Spanish, multicentre, open-label, single arm phase II study

    Antiproliferative effects of lanreotide autogel in patients with progressive, well-differentiated neuroendocrine tumours: a Spanish, multicentre, open-label, single arm phase II st... mā Marta Martín-Richard, Bartomeu Massutí, Eva Margarita Pineda, Vicente Alonso, Maribel Mármol, Daniel Castellano, Emilio Fonseca, António Galán de Mera, Marta Llanos, María Ángeles Sala, Carles Pericay, Fernando Rivera, Javier Sastre, Ángel Segura, María Quindós, Pascal Maisonobe

    I whakaputaina 2013
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  14. 14
    The Effectiveness of Botulinum Toxin Type A (BoNT-A) Treatment in Brazilian Patients with Chronic Post-Stroke Spasticity: Results from the Observational, Multicenter, Prospective BCause Study

    The Effectiveness of Botulinum Toxin Type A (BoNT-A) Treatment in Brazilian Patients with Chronic Post-Stroke Spasticity: Results from the Observational, Multicenter, Prospective B... mā Patricia Khan, Marcelo Riberto, João Amaury Frances, Regina Helena Morganti Fornari Chueire, Ana Cristina Ferreira Garcia, Denise Rodrigues Xerez, Tae Mo Chung, Lucia Helena Costa Mercuri, Alexandre Luiz Longo, Sérgio Lianza, Pascal Maisonobe, Viviane C. Ruiz-Schutz

    I whakaputaina 2020
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  15. 15
    Post Hoc Subgroup Analysis of the BCause Study Assessing the Effect of AbobotulinumtoxinA on Post-Stroke Shoulder Pain in Adults

    Post Hoc Subgroup Analysis of the BCause Study Assessing the Effect of AbobotulinumtoxinA on Post-Stroke Shoulder Pain in Adults mā Marcelo Riberto, João Amaury Frances, Regina Helena Morganti Fornari Chueire, Ana Cristina Ferreira Garcia, Denise Rodrigues Xerez, Tae Mo Chung, Lucia Helena Costa Mercuri, Sérgio Lianza, Eduardo de Melo Carvalho Rocha, Pascal Maisonobe, Thais Cuperman-Pohl, Patricia Khan

    I whakaputaina 2022
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:

Ngā utauta rapu: